S&N sells majority stake of orthobiologics unit to VC Essex to set up JV
This article was originally published in Clinica
Executive Summary
Smith & Nephew is selling a major stake in its non-core orthobiologics unit to healthcare private equity firm Essex Woodlands and the business will be set up as a joint venture. The transaction includes an injection of funds to S&N and is expected to close in the "next few months", pending regulatory approval.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.